S. 2665: Drug Shortage Prevention Act of 2025

S. 2665 is a federal bill in the 119th Congress. Currently, drug manufacturers only have to notify the federal government about permanent discontinuances or manufacturing interruptions for certain critical drugs. Under the new changes, drug makers must also notify the Food and Drug Administration when… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.